V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213471 | 20079908 | 1.69 | 75.7 | Curative (C) | 2017-05-28 | 2017-06-14 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100278900 |
| 20213472 | 20079909 | null | 117 | Palliative (P) | 2016-11-18 | 2016-11-18 | LANREOTIDE | 02 | N | LANREOTIDE | 101722952 |
| 20213473 | 20079910 | 0 | null | Palliative (P) | 2020-01-27 | 2020-01-27 | LANREOTIDE | 02 | N | LANREOTIDE | 100838127 |
| 20213474 | 20079911 | 1.6 | 66 | Palliative (P) | 2017-07-28 | 2017-09-01 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100089339 |
| 20213475 | 20079912 | 1.68 | 72.2 | Palliative (P) | null | 2019-05-11 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100367538 |
| 20213476 | 20079913 | 1.64 | 78.5 | Neo-adjuvant (N) | 2019-06-15 | 2019-06-15 | IMATINIB | 02 | N | IMATINIB | 100318448 |
| 20213477 | 20079914 | 1.68 | 92.6 | null | 2017-01-23 | 2017-01-24 | Cape+Cisplatin+Trastuzumab Main | 02 | null | IMATINIB | 100951158 |
| 20213478 | 20079915 | null | 75.8 | null | 2019-03-23 | 2019-04-04 | HCX (Cape + Cisp + Tras) - Load | 02 | null | LANREOTIDE | 101144329 |
| 20213479 | 20079916 | 1.6 | 71.5 | Palliative (P) | 2018-03-08 | 2018-04-10 | LANREOTIDE | 02 | Y | LANREOTIDE | 100950905 |
| 20213480 | 20079917 | 1.78 | 99.9 | Palliative (P) | 2017-11-20 | 2017-12-08 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101256600 |
| 20213481 | 20079918 | 1.79 | 115 | Curative (C) | 2018-03-18 | 2018-04-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100126598 |
| 20213482 | 20079919 | 1.6 | 67.7 | Palliative (P) | 2016-06-27 | 2016-07-11 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 100489576 |
| 20213487 | 20079921 | 1.73 | 78.8 | Palliative (P) | 2019-09-28 | 2019-10-05 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 101762559 |
| 20213488 | 20079922 | 1.78 | 98.4 | Palliative (P) | 2018-04-13 | 2018-04-20 | Trial Unspecified | 02 | N | TRIAL | 101228188 |
| 20213489 | 20079923 | 1.53 | 75.9 | Palliative (P) | 2017-12-23 | 2018-01-05 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 101595289 |
| 20213491 | 20079924 | 1.67 | 55 | Palliative (P) | 2018-12-03 | 2018-12-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101786865 |
| 20213494 | 20079926 | null | null | null | 2019-05-09 | 2019-05-09 | LANREOTIDE | 02 | N | LANREOTIDE | 101438629 |
| 20213495 | 20079927 | 1.52 | 66.8 | null | 2018-02-21 | 2018-03-11 | HCX (Cape + Cisp + Tras) - Load | 02 | null | IMATINIB | 100443845 |
| 20213496 | 20079928 | 1.64 | 64.7 | Palliative (P) | 2019-02-19 | 2019-02-26 | Cape+Cisplatin+Trastuzumab Load | 02 | N | LANREOTIDE | 100657932 |
| 20213497 | 20079929 | null | 61 | null | 2017-09-02 | 2017-09-05 | LANREOTIDE | 02 | null | LANREOTIDE | 100600283 |
| 20213498 | 20079930 | 1.72 | 118.3 | Palliative (P) | 2017-10-03 | 2017-10-17 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101460490 |
| 20213499 | 20079931 | 1.69 | 83.5 | Palliative (P) | 2019-06-12 | 2019-06-19 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101447137 |
| 20213500 | 20079932 | 1.8 | 75.9 | Curative (C) | 2016-07-12 | 2016-07-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101740322 |
| 20213501 | 20079933 | 1.71 | 70.4 | null | 2018-01-01 | 2018-01-02 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100684126 |
| 20213502 | 20079934 | 1.8 | null | Palliative (P) | 2018-11-17 | 2018-11-19 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101743604 |
| 20213503 | 20079935 | 1.86 | 96 | Curative (C) | 2019-10-05 | 2019-10-19 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100152912 |
| 20213504 | 20079936 | 1.68 | 89.7 | Curative (C) | null | 2020-01-06 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100773418 |
| 20213506 | 20079938 | 1.5 | 63.1 | Palliative (P) | 2016-09-05 | 2016-09-25 | HCX | 02 | N | IMATINIB | 100865098 |
| 20213507 | 20079939 | null | 77.2 | Curative (C) | 2019-03-13 | 2019-03-26 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 100168120 |
| 20213508 | 20079940 | 1.8 | 95 | Disease modification (D) | 2019-02-23 | 2019-03-23 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101614693 |
| 20213509 | 20079941 | 1.66 | 64.5 | null | 2018-03-12 | 2018-03-12 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | TRIAL | 101165402 |
| 20213510 | 20079942 | 1.53 | 63.3 | Palliative (P) | 2022-03-15 | 2022-04-05 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101520468 |
| 20213511 | 20079943 | 1.75 | 81 | null | 2018-03-02 | 2018-03-09 | Cape+Cisplatin+Trastuzumab Main | 02 | null | IMATINIB | 101305834 |
| 20213512 | 20079944 | 1.57 | 46.4 | Palliative (P) | 2016-12-30 | 2017-01-14 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 100838171 |
| 20213513 | 20079945 | 0 | 59.9 | Palliative (P) | 2018-03-22 | 2018-03-24 | IMATINIB | 02 | N | IMATINIB | 101208693 |
| 20213514 | 20079946 | 1.76 | 0 | Curative (C) | 2016-09-09 | 2016-09-24 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101725972 |
| 20213515 | 20079947 | 1.8 | 71.2 | Curative (C) | 2016-12-20 | 2017-01-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100208130 |
| 20213516 | 20079948 | 0 | 79.7 | Neo-adjuvant (N) | 2017-09-21 | 2017-09-28 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 100332914 |
| 20213517 | 20079949 | 1.68 | 76.1 | null | 2019-09-07 | 2019-09-13 | LANREOTIDE | 02 | null | LANREOTIDE | 100228002 |
| 20213518 | 20079950 | 1.71 | 85.9 | 03 | 2017-01-11 | 2017-01-12 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 100980451 |
| 20213519 | 20079951 | null | null | Palliative (P) | 2018-04-24 | 2018-04-24 | GO2 TRIAL | 01 | Y | TRIAL | 100410799 |
| 20213521 | 20079952 | 1.75 | 81.6 | Curative (C) | 2019-07-27 | 2019-07-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | FLUOROURACIL + MITOMYCIN + RT | 100487138 |
| 20213522 | 20079953 | 1.69 | 49 | Curative (C) | 2018-01-18 | 2018-01-28 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100724565 |
| 20213523 | 20079954 | 1.78 | 82 | Neo-adjuvant (N) | 2019-03-13 | 2019-03-20 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101584666 |
| 20213524 | 20079955 | 1.61 | 84.3 | Palliative (P) | 2019-05-07 | 2019-06-07 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101670821 |
| 20213525 | 20079956 | 0 | 90.4 | Palliative (P) | 2018-09-15 | 2018-10-29 | LANREOTIDE | 02 | N | LANREOTIDE | 101452948 |
| 20213526 | 20079957 | 1.83 | 50.4 | Palliative (P) | 2017-09-15 | 2017-09-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101800053 |
| 20213527 | 20079958 | 1.72 | 88 | Palliative (P) | 2017-05-08 | 2017-05-20 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 100627442 |
| 20213528 | 20079959 | 1.64 | 75.45 | Neo-adjuvant (N) | 2016-07-18 | 2016-07-18 | IMATINIB | 02 | N | IMATINIB | 100229334 |
| 20213529 | 20079960 | 1.59 | 56.35 | Palliative (P) | 2017-01-16 | 2017-03-08 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101500268 |